| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −9.4× | −1.7× | |
| Price / Book | 2.5× | 2.0× | |
| Price / Sales | 8.0× | 3.9× | |
| Price / Free cash flow | −10.5× | −1.5× | |
| EV / EBITDA | −9.9× | −1.2× | |
| Earnings yield | −10.6% | −14.4% | |
| Free cash flow yield | −9.5% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,301.33 | +4.92% | $1.23T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.71 | +2.33% | $625.87B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.17 | +1.94% | $509.23B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $416.73 | +2.42% | $374.05B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.35 | +3.29% | $366B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.75 | +1.70% | $281.59B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.08 | +2.52% | $260.68B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $685.41 | +0.89% | $253.43B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $435.46 | +2.48% | $235.42B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.34 | +1.48% | $192.61B | 22.3× | 37.5% | +29.9% |
